Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis.
CTNS
Cornea crystal
Mutations
Ocular cystinosis
Tunisian families
Journal
Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558
Informations de publication
Date de publication:
06 May 2022
06 May 2022
Historique:
received:
27
10
2021
accepted:
12
04
2022
entrez:
7
5
2022
pubmed:
8
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
Ocular cystinosis is a rare autosomal recessive disorder characterized by intralysosomal cystine accumulation in renal, ophthalmic (cornea, conjunctiva), and other organ abnormalities. Patients with ocular cystinosis are mostly asymptomatic and typically experience mild photophobia due to cystine crystals in the cornea observed accidently during a routine ocular examination. The ocular cystinosis is associated with different mutations in CTNS gene. Cysteamine therapy mostly corrects the organ abnormalities. This study was performed in collaboration with the department of ophthalmology of Farhat Hached Hospital. The Optical Coherence Tomography (OCT) of the cornea and retinal photography were used to search cystine crystals within the corneas and conjunctiva in eight Tunisian patients. Screening for the common 57-kb deletion was performed by standard multiplex PCR, followed by direct sequencing of the entire CTNS gene. The studied patients were found to have cystine crystal limited anterior corneal stroma and the conjunctiva associated with retinal crystals accumulation. CTNS gene sequencing disclosed 7 mutations: three missense mutations (G308R, p.Q88K, and p.S139Y); one duplication (C.829dup), one framshift mutation (p.G258f), one splice site mutation (c.681 + 7delC) and a large deletion (20,327-bp deletion). Crystallographic structure analysis suggests that the novel mutation p.S139Y is buried in a first transmembrane helix closed to the lipid bilayer polar region, introducing a difference in hydrophobicity which could affect the hydrophobic interactions with the membrane lipids. The second novel mutation p.Q88K which is located in the lysosomal lumen close to the lipid membrane polar head region, introduced a basic amino acid in a region which tolerate only uncharged residue. The third missense mutation introduces a positive change in nonpolar tail region of the phospholipid bilayer membrane affecting the folding and stability of the protein in the lipid bilayer. Our data demonstrate that impaired transport of cystine out of lysosomes is the most common, which is obviously associated with the mutations of transmembrane domains of cystinosine resulting from a total loss of its activity.
Sections du résumé
BACKGROUND
BACKGROUND
Ocular cystinosis is a rare autosomal recessive disorder characterized by intralysosomal cystine accumulation in renal, ophthalmic (cornea, conjunctiva), and other organ abnormalities. Patients with ocular cystinosis are mostly asymptomatic and typically experience mild photophobia due to cystine crystals in the cornea observed accidently during a routine ocular examination. The ocular cystinosis is associated with different mutations in CTNS gene. Cysteamine therapy mostly corrects the organ abnormalities.
METHODS
METHODS
This study was performed in collaboration with the department of ophthalmology of Farhat Hached Hospital. The Optical Coherence Tomography (OCT) of the cornea and retinal photography were used to search cystine crystals within the corneas and conjunctiva in eight Tunisian patients. Screening for the common 57-kb deletion was performed by standard multiplex PCR, followed by direct sequencing of the entire CTNS gene.
RESULTS
RESULTS
The studied patients were found to have cystine crystal limited anterior corneal stroma and the conjunctiva associated with retinal crystals accumulation. CTNS gene sequencing disclosed 7 mutations: three missense mutations (G308R, p.Q88K, and p.S139Y); one duplication (C.829dup), one framshift mutation (p.G258f), one splice site mutation (c.681 + 7delC) and a large deletion (20,327-bp deletion). Crystallographic structure analysis suggests that the novel mutation p.S139Y is buried in a first transmembrane helix closed to the lipid bilayer polar region, introducing a difference in hydrophobicity which could affect the hydrophobic interactions with the membrane lipids. The second novel mutation p.Q88K which is located in the lysosomal lumen close to the lipid membrane polar head region, introduced a basic amino acid in a region which tolerate only uncharged residue. The third missense mutation introduces a positive change in nonpolar tail region of the phospholipid bilayer membrane affecting the folding and stability of the protein in the lipid bilayer.
CONCLUSIONS
CONCLUSIONS
Our data demonstrate that impaired transport of cystine out of lysosomes is the most common, which is obviously associated with the mutations of transmembrane domains of cystinosine resulting from a total loss of its activity.
Identifiants
pubmed: 35524314
doi: 10.1186/s13000-022-01221-8
pii: 10.1186/s13000-022-01221-8
pmc: PMC9074260
doi:
Substances chimiques
Amino Acid Transport Systems, Neutral
0
CTNS protein, human
0
Lipid Bilayers
0
Cystine
48TCX9A1VT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Informations de copyright
© 2022. The Author(s).
Références
JIMD Rep. 2014;14:87-97
pubmed: 24464559
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803
Hum Mol Genet. 2004 Jul 1;13(13):1361-71
pubmed: 15128704
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Pediatr Res. 2000 Jan;47(1):17-23
pubmed: 10625078
Ophthalmol Ther. 2017 Jun;6(1):93-104
pubmed: 28477325
Surv Ophthalmol. 2007 Jan-Feb;52(1):97-105
pubmed: 17212992
J Biol Chem. 2001 Apr 20;276(16):13314-21
pubmed: 11150305
Pediatr Nephrol. 2012 Nov;27(11):2123-2127
pubmed: 22664570
BMC Med Genomics. 2021 Aug 23;14(1):208
pubmed: 34425818
Mol Genet Metab. 2000 Sep-Oct;71(1-2):100-20
pubmed: 11001803
Meta Gene. 2015 Jul 25;5:144-9
pubmed: 26266097
Pediatr Nephrol. 2008 Jun;23(6):863-78
pubmed: 18008091
Nat Genet. 1998 Apr;18(4):319-24
pubmed: 9537412
Eur J Hum Genet. 2003 Jul;11(7):503-8
pubmed: 12825071
Hum Mol Genet. 1999 Dec;8(13):2507-14
pubmed: 10556299
EMBO J. 2001 Nov 1;20(21):5940-9
pubmed: 11689434